WEIGHT-LOSS DRUGS RESHAPE CONSUMER BEHAVIOR
GLP-1 drugs are changing consumer behaviors, prompting businesses to find news ways to meet shifting customer demands. Michael Yoshida reports.
As featured on
Alarmed by rising rates of obesity, public health officials have urged Americans for decades to eat better, move more and make healthier choices. Yet obesity rates kept rising, peaking at 40% of Americans in 2022. The decline since then is linked to something else: a new class of medications known as GLP-1.
